Proteolysis-focusing on chimeras (PROTACs) and molecular glue degraders (MGDs) are probably the most maturely created TPD strategies. On this critique, we concentrate on both equally preclinical experiments and clinical trials to offer an extensive summary of the security and medical success of PROTACs and MGDs in hematologic malignancies in the https://daltonahnr42852.bleepblogs.com/32213513/the-md-224-diaries